Nucleate and Mercury Announce Strategic Partnership to Empower the Next Generation of Biotech Founders
BOSTON, MA — March 3rd, 2026 — Nucleate, the nonprofit organization dedicated to empowering the next generation of biotech founders, today announced the renewal of a strategic partnership with Mercury, a fintech platform that streamlines financial operations for early-stage companies, helping founders move fast and stay focused. This collaboration aims to provide early-stage life sciences entrepreneurs with the specialized financial tools, capital management resources, and investor networks necessary to scale breakthrough scientific innovations.
As a Nucleate partner, Mercury is committed to our shared mission of supporting life science founders. Their partnership extends beyond banking, offering valuable programs such as Investor Connect, a VC matchmaking service that facilitates investor introductions to participating VCs. Additionally, Mercury hosts in-person events across multiple geographies, enabling founders and investors to build meaningful connections.
“Nucleate is committed to removing the barriers that visionary scientists face when translating research into impactful companies,” said Oliver Dodd, Executive Director & Co-Founder, at Nucleate. “Partnering with Mercury allows our founders to simplify their financial infrastructure from day one, ensuring they can focus their energy on clinical and scientific milestones rather than administrative hurdles.”
“We’re honored to partner with Nucleate and back the founders shaping the future of life sciences,” said Kelly Caviglia. “Supporting programs like this is core to Mercury’s mission, we’re excited to help equip emerging biotech leaders with the financial tools and community they need to build and scale transformative companies.”
This partnership reinforces Nucleate’s position as a leading center for biotech innovation by fortifying its network of partners that offer essential support for biotech ventures. Activator teams and alumni will benefit from $500 deposit bonus upon reaching $10,000 in deposits, a complimentary 409A valuation valued at $900 provided through Morgan Stanley, exclusive platform discounts for services such as AWS, Slack, and QuickBooks, and free personal banking for eligible team members on your account.
About Nucleate
Nucleate is a student-led nonprofit organization dedicated to empowering the next generation of biotech founders. With chapters in over 30 academic ecosystems globally, Nucleate identifies, educates, and accelerates the most promising life sciences ventures through its flagship Activator program. For more information, visit nucleate.org.
About Mercury
Mercury is the fintech platform that over 100,000 startups use for banking* and beyond. Mercury helps founders and finance teams manage their money with confidence through a seamless experience that integrates banking, credit cards, treasury, and venture debt. For more information, visit mercury.com.
Mercury is a financial technology company, not a bank. Banking services provided by Choice Financial Group and Evolve Bank & Trust ®; Members FDIC.
